NEW YORK (GenomeWeb) – Alere reported today that its first quarter revenues declined 2 percent year over year as currency translation hit its top line.

The Waltham, Massachusetts-based diagnostics firm reported revenues of $610.4 million for the quarter ended March 31, compared to $625 million for the first quarter of 2014. On average, Wall Street analysts had estimated revenues of $612.9 million.

The Q1 revenues included a negative foreign currency impact of $28.7 million, Alere said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.